Updated data from a trial of Johnson & Johnson’s experimental “pretzel” showed that more than 80% of bladder ...
A group of Democratic and Republican senators introduced a bill on Thursday that calls for $275 million toward federal ...
Chroma Medicine laid off an undisclosed number of employees earlier this week, as the privately held startup focuses its ...
Sarepta Therapeutics’ chief scientist suggested that the FDA was ahead of schedule in reviewing the company’s application to ...
Jang-Ho Cha had no interest in leaving his post at Novartis, where he led translational medicine for the pharma giant’s work ...
Newly appointed CEO Joe Papa outlined his vision for Emergent BioSolutions, which includes winding down two facilities and ...
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...
AstraZeneca is working on moving its BTK inhibitor Calquence into earlier stages of mantle cell lymphoma, releasing what it ...
For biosimilars to win, AbbVie has to lose, according to Boehringer Ingelheim. The German drugmaker on Wednesday said that ...
The Senate Finance Committee released a bipartisan draft legislation on Friday morning that would give Medicare bonuses to healthcare providers that help fight generic drug shortages. “It is ...
MPM BioImpact and Novo Holdings are among a group of investors pouring $103 million into a psychedelic biotech that MPM took ...
Bristol Myers Squibb will give back a preclinical cancer drug to Schrödinger, returning the SOS1 inhibitor that was part of a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results